Summary: Hair loss from GLP-1 medications is typically temporary telogen effluvium caused by rapid weight loss and nutritional changes, manageable through adequate protein intake, micronutrient optimisation, and moderating weight reduction rate
MOTS-c : Strong mitochondrial peptide for metabolism, exercise performance, energy, and insulin sensitivity
Cells were gently resuspended in tubes containing 10 mL of pre-warmed RPMI 1640 media (Gibco) supplemented with 10% FBS (Biological Industries), L-glutamine (2 mM), penicillin (100 U/mL, Biological Industries), streptomycin (0.1 mg/mL, Biological Industries) and Benzonase Nuclease (1:10,000, Millipore), and centrifuged for 7 min at 400 g , RT
Clinical trials show GLP-1 therapy reduces body weight, improves insulin resistance markers, lowers testosterone levels, and increases menstrual regularity in women with PCOS